Loading in 2 Seconds...
Loading in 2 Seconds...
The latest market report published by Credence Research, Inc. “Heparin Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global heparin market was valued at US$ 7,714.0 Mn in 2016, and is expected to reach US$ 14,853.1 Mn by 2025 expanding at a CAGR of 7.21 % from 2017 to 2025. \nBrowse the full report Heparin Market - Growth, Future Prospects, Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/heparin-market\n
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
The latest market report published by Credence Research, Inc. “Heparin Market -
Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global heparin market
was valued at US$ 7,714.0 Mn in 2016, and is expected to reach US$ 14,853.1 Mn by 2025
expanding at a CAGR of 7.21 % from 2017 to 2025.
Browse the full report Heparin Market - Growth, Future Prospects, Competitive
The heparin crisis which took place in 2008 due to contaminated batches of
unfragmented heparin imported from China resulted in fatal adverse events such as rapid
fall in blood pressure and death. This event led to the entry of more safe and effective low
and ultra-low molecular weight heparin. Still pharmacovigilence agencies have reported
several heparin related serious adverse events which demands for safer heparin products
for medicinal use. Researchers at University of North Carolina have developed a low
molecular weight heparin through chemoenzymatic process by using C5-epimerase and
recombinant O-sulfotransferase enzymes. The newly synthesized heparin will be reversed
by protamine sulphate and will be cleared by liver and not by the kidneys, and thus will
overcome the earlier heparin related adverse events.
Rising prevalence of venous thromboembolism and good bioavailability due to longer
half-life low molecular weight heparin leads the products segment. Ultra-low molecular
weight heparin will lead the market during the forecast period as it has projected better
results in DVT/PE induced in patients undergoing cancer chemotherapy.
Subcutaneous is the most desirable route of administration owing to excellent drug
pharmacokinetic profile for heparin and is relatively cheaper. Intravenous route is used
for its fast onset of action due to high plasma protein binding and is used to perform open
heart surgery, blood transfusion, and kidney dialysis.
North America is the clear leader in global heparin market as a result of rising prevalence
of venous thromboembolism. In United States about 33 % of the people suffering with
venous thromboembolism has a recurrence within ten years. Enhanced investment in the
research and development of heparin products to address the problems associated with
heparin overdose has a positive effect on market growth of North America. Increasing
number of venous thromboembolism encountered in patients undergoing cancer
chemotherapy and supportive regulatory environment for heparin products will be
responsible for the remarkable growth of Asia Pacific in global heparin market.
Market players engaged in the manufacture and sale of heparin products are Aspen
Holdings, Teva Pharmaceutical Industries Ltd., Baxter International, Inc., Syntex S.A., B.
Braun Melsungen AG, Sanofi AG, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., LEO Pharma
A/S., and Fresenius SE & Co. KGaA among others.
Key Market Movements
Increasing research activities conducted on ultra-low molecular weight heparin
and synthetic heparin reporting promising therapeutic applications
Patent expiry of low molecular weight heparin will boost the generic market in the
Table of Content
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Heparin Market Portraiture
2.1.1. Global Heparin Market, by Product, 2016 (Value %)
2.1.2. Global Heparin Market, by Route of Administration, 2016 (Value %)
2.1.3. Global Heparin Market, by Geography, 2016 (Value %)
Chapter 3. Heparin Market: Dynamics and Future Outlook
3.1. Market Overview
3.5. Attractive Investment Proposition, by Geography
3.6. Top 3 Countries: Global Heparin Market, 2015-2025 (US$ Mn)
3.7. Competitive Landscape : Global Heparin Market, by Key Players, 2015-2025
Chapter 4. Global Heparin Market, by Product, 2015 – 2025 (US$ Mn)
4.2. Attractive Investment Proposition: Global Heparin Market, by Product, 2016
4.3. Unfractionated Heparin
4.4. Low Molecular Weight Heparin
4.5. Ultra-Low Molecular Weight Heparin
Chapter 5. Global Heparin Market, by Route of Administration, 2015 –
2025 (US$ Mn)
5.1.1. Attractive Investment Proposition: Global Heparin Market, by Route of
Credence Research is a worldwide market research and counseling firm that serves
driving organizations, governments, non-legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to their
execution and understand their most imperative objectives. Over almost a century, we’ve
manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager